Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLHL21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNF217-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KMT5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRWD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MAPK8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WWTR1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929240 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLUAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP1LC3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC642533 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
L3MBTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on